Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R First

Transplantation proceedings

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|May 30, 2001
Tailoring immunosuppressive therapy based on donor and recipient risk factorsM R First
Transplantation Proceedings|January 1, 1998
The donor supplyM R First
Transplantation Proceedings|March 27, 2001
The organ shortage and allocation issuesM R First
Transplantation Proceedings|March 20, 1999
Immunologically high-risk recipient strategiesM R First
Transplantation Proceedings|February 1, 1997
Cadaveric organ procurement--an overview of two aspects: donor hospital networks, and minority donationM R First
Transplantation Proceedings|February 1, 1997
Controversies in organ donation: minority donation and living unrelated renal donorsM R First
Transplantation Proceedings|April 1, 1986
Development and incidence of cancer following cyclosporine therapyI Penn, M R First
Transplantation Proceedings|September 24, 1998
Malignancies complicating organ transplantationM R First, V R Peddi
Transplantation Proceedings|February 1, 1995
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulationsT J Schroeder, S Hariharan, M R First
Transplantation Proceedings|April 1, 1993
Antibody response to OKT3 and methods for monitoringT J Schroeder, S Hariharan, M R First
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|May 30, 2001
Tailoring immunosuppressive therapy based on donor and recipient risk factorsM R First
Transplantation Proceedings|January 1, 1998
The donor supplyM R First
Transplantation Proceedings|March 27, 2001
The organ shortage and allocation issuesM R First
Transplantation Proceedings|March 20, 1999
Immunologically high-risk recipient strategiesM R First
Transplantation Proceedings|February 1, 1997
Cadaveric organ procurement--an overview of two aspects: donor hospital networks, and minority donationM R First
Transplantation Proceedings|February 1, 1997
Controversies in organ donation: minority donation and living unrelated renal donorsM R First
Transplantation Proceedings|April 1, 1986
Development and incidence of cancer following cyclosporine therapyI Penn, M R First
Transplantation Proceedings|September 24, 1998
Malignancies complicating organ transplantationM R First, V R Peddi
Transplantation Proceedings|February 1, 1995
Variations in bioavailability of cyclosporine and relationship to clinical outcome in renal transplant subpopulationsT J Schroeder, S Hariharan, M R First
Transplantation Proceedings|April 1, 1993
Antibody response to OKT3 and methods for monitoringT J Schroeder, S Hariharan, M R First
Pageof 10